CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.57B, above the global median of $1.15B
- FinancialsAltman Z-Score 8.9: safe zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
10.61BCNY1.57B · vs all stocks (USD)
Trailing P/E
27.67xRevenue (TTM)
2.12BCNY314.89M · vs all stocks (USD)
Profit Margin
19.38%Beta
0.0850xvs all stocks
52-Week Change
20.77%vs all stocks
Market Capitalization
10.61BCNY1.57B · vs all stocks (USD)
Enterprise Value
10.20BCNY1.51B · vs all stocks (USD)
Trailing P/E
27.67xForward P/E
34.00xPrice to Sales (TTM)
5.23xPrice to Book (MRQ)
4.65xEnterprise to Revenue
4.80xEnterprise to EBITDA
30.66xGross Margin
45.58%Profit Margin
19.38%Operating Margin
14.09%Return on Assets (TTM)
5.07%Return on Equity (TTM)
19.11%Revenue (TTM)
2.12BCNY314.89M · vs all stocks (USD)
Revenue per Share (TTM)
0.9690CNYUpdated Aug 19, 2026Quarterly Revenue Growth
-2.20%Gross Profit (TTM)
942.45MCNY139.77M · vs all stocks (USD)
EBITDA (TTM)
404.96MCNY60.06M · vs all stocks (USD)
Net Income (TTM)
411.58MCNY61.04M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
57.50%Operating Cash Flow (TTM)
239.59MCNY35.53M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
38.20MCNY5.67M · vs all stocks (USD)
5-Year Average Dividend Yield
0.59%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
15.90MCNYFY2025 · Dec 31, 2025Revenue
2.14BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.17BCNYFY2025 · Dec 31, 2025Gross Profit
968.37MCNYFY2025 · Dec 31, 2025Operating Income
268.78MCNY39.86M · vs all stocks (USD)
Pre-tax Income
409.62MCNYFY2025 · Dec 31, 2025Income Tax Expense
27.26MCNYFY2025 · Dec 31, 2025Net Income
382.36MCNYFY2025 · Dec 31, 2025EBIT
412.10MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
503.62MCNYFY2025 · Dec 31, 2025Research & Development
78.43MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
612.94MCNYFY2025 · Dec 31, 2025Other Operating Expenses
32.95MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
5.10MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
2.48MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1719CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1686CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
2.19BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
2.19BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
382.36MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-5.45MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
360.58MCNYFY2025 · Dec 31, 2025Free Cash Flow
348.18MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
395.84MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
382.36MCNYFY2025 · Dec 31, 2025Other Non-cash Items
4.23MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-6.63MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-19.38MCNYFY2025 · Dec 31, 2025Capital Expenditures
-12.39MCNYFY2025 · Dec 31, 2025Net Acquisitions
-299.34KCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.63BCNYFY2025 · Dec 31, 2025Sale of Investments
1.31BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-332.35MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
90.00MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-1.21MCNYFY2025 · Dec 31, 2025Other Financing Charges
-107.22MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-18.43MCNYFY2025 · Dec 31, 2025Shares Outstanding
2.23BSharesUpdated Aug 19, 2026Float Shares
1.94BSharesUpdated Aug 19, 2026% Held by Insiders
9.37%vs all stocks
% Held by Institutions
11.25%vs all stocks
Total Cash (MRQ)
947.73MCNY140.55M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.4250CNYUpdated Aug 19, 2026Total Debt (MRQ)
21.55MCNY3.20M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0090xCurrent Ratio (MRQ)
1.90xBook Value per Share (MRQ)
1.07CNYUpdated Aug 19, 2026Total Assets
3.13BCNY464.86M · vs all stocks (USD)
Total Current Assets
1.32BCNYFY2025 · Dec 31, 2025Total Liabilities
825.00MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.82BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
27.15MCNYFY2025 · Dec 31, 2025Total Current Liabilities
797.85MCNYFY2025 · Dec 31, 2025Cash
396.40MCNYFY2025 · Dec 31, 2025Cash Equivalents
500.00CNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
396.40MCNYFY2025 · Dec 31, 2025Other Short-term Investments
533.66MCNYFY2025 · Dec 31, 2025Accounts Receivable
126.61MCNYFY2025 · Dec 31, 2025Inventory
205.88MCNYFY2025 · Dec 31, 2025Accounts Payable
65.13MCNYFY2025 · Dec 31, 2025Short-term Debt
91.44MCNYFY2025 · Dec 31, 2025Other Current Liabilities
5.52MCNYFY2025 · Dec 31, 2025Long-term Debt
566.39KCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
1.08MCNYFY2025 · Dec 31, 2025Common Stock (Book)
2.23BCNYFY2025 · Dec 31, 2025Retained Earnings
-304.54MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
2.31BCNY342.51M · vs all stocks (USD)
Treasury Stock
42.93MCNYFY2025 · Dec 31, 202552-Week Low
2.37CNYUpdated Aug 19, 202652-Week High
5.10CNYUpdated Aug 19, 202652-Week Change
20.77%vs all stocks
Beta
0.0850xvs all stocks
50-Day MA
2.94CNYUpdated Aug 19, 2026200-Day MA
3.23CNYUpdated Aug 19, 2026Avg 10-Day Volume
407.39MSharesUpdated Aug 19, 2026Avg 30-Day Volume
194.72MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
0.1800CNYUpdated Aug 19, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How does this company use capital?
Three Turnover Ratios Elevated
Collects fast, clears inventory fast, and pays suppliers fast too.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 8.9: safe zoneNotable
Altman Z-Score: 8.90
High earnings qualityNotable
Earnings Quality Score: 0.54
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.57B, above the global median of $1.15BNotable
Market cap (USD): 1,574,081,748.976Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Forte Biosciences, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Sihuan Pharmaceutical Holdings Group Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Yantai Dongcheng Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Recursion Pharmaceuticals, Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Hualan Biological Engineering Inc.
Tier 1ProductionApproval-Gated PipelineRule
Intellia Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Enovis Corporation
Tier 1ProductionApproval-Gated PipelineRuleRisk
Vir Biotechnology Inc.
Tier 1ProductionApproval-Gated PipelineRule
Green Thumb Industries Inc.
Tier 1ProductionApproval-Gated PipelineFlowRule
Consun Pharmaceutical Group Limited
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Copart Inc.
2 interpretationsThree Turnover Ratios ElevatedMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Odontoprev S.A.
2 interpretationsThree Turnover Ratios ElevatedMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cavco Industries Inc.
2 interpretationsThree Turnover Ratios ElevatedMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities